NRIX: Nurix Therapeutics Inc

11.88 USD 0.16 (1.33%)

Sector: Atención Sanitaria Básica: US Dollar Divisa de beneficio: US Dollar

El tipo de cambio de NRIX de hoy ha cambiado un -1.33%. En este caso, el precio mínimo en el mercado ha alcanzado 11.78, mientras que el máximo ha alcanzado 12.33.

Siga la dinámica de la pareja de divisas Nurix Therapeutics Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.

Gráfico a pantalla completa

NRIX News

Investing 22:57 Nurix therapeutics (NRIX) CSO Hansen sells $51k in stock
Investing 22:54 Nurix Therapeutics’ ring sells $46k in stock to cover tax obligations
Investing 22:52 Nurix Therapeutics CFO van Houte sells $51,695 in shares
Investing 14:58 Morgan Stanley lowers Nurix stock price target to $16 on higher spend
TipRanks 17:03 Top 3 Trending Stocks, According to Analysts – 7/11/2025 - TipRanks.com
Investing 12:12 Stifel maintains Buy rating on Nurix stock, sees $4.5B peak sales potential
Investing 11:35 Nurix stock price target lowered to $26 by UBS on increased OpEx
Investing 11:14 Goldman Sachs initiates Nurix stock with Buy rating, $182 price target
Investing 11:04 Stifel reiterates Buy rating on Nurix stock, sees $4.5B peak sales potential
Investing 00:02 Nurix earnings beat by $0.19, revenue topped estimates
Investing 20:19 Nurix Therapeutics beats quarterly expectations on strong collaboration revenue
Investing 11:45 Nurix stock maintains Buy rating at H.C. Wainwright on positive BTK degrader data
Seeking Alpha 01:14 Tracking Baker Brothers Portfolio – Q1 2025 Update
Investing 20:12 Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 13:58 Nurix stock price target reiterated at $30 by UBS on positive trial data
Investing 13:52 Nurix stock price target raised to $28 from $27 at RBC Capital
Investing 11:16 Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chroni
Investing 11:13 Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congr
Investing 11:18 Stifel analysts maintain Buy rating on Nurix stock after SNY deal
Investing 14:31 UnitedHealth, Biontech lead Monday’s market cap stock movers
Investing 12:36 Sanofi extends license option with Nurix’s STAT6 program
Benzinga 12:12 Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout - Nurix Therapeutics (NASDAQ:NRIX), Blueprint Medicines (NASDAQ:BPMC), Sanofi (NASDAQ:SNY)
Investing 11:08 Nurix secures additional $15 million from Sanofi license deal
Investing 11:24 Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference

Rango diario

11.78 12.33

Rango anual

8.18 29.56

Cierres anteriores: 11.89
Open: 12.04

Bid: 11.88
Ask: 12.18

Low: 11.78
High: 12.33

Volumen: 2.183 K

Cambio diario: -1.33%
Cambio mensual: 4.30%

Cambio a 6 meses: -38.79%
Cambio anual: -46.00%

31 julio, jueves